Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Pharmaceutical Independence Long-Term Readiness Reform Act
Client: RETIRESAFE · Firm: RETIRESAFE
Worked within the Protect Medicare Part D working group to protect and improve Medicare Part D. Continued our support of 340B reform including our support of HR 4710, the Pause Act, which would improve oversight and increase program accountability. In January RetireSafe commented on the Proposed Rule on Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses released in the Federal Register on November 30, 2018. We proposed that the only meaningful change would be one that lowered the patients out-ot-pocket costs. Sent a letter to the Administration concerning some of the proposed changes to Medicare, especially Part D, that we felt threatened the access and safety of older Americans. talked about importance of vaccinations and accessibility. discussed our stance against drug importation.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
RETIRESAFE via RETIRESAFE
2024 · fourth_quarter · 4A
cuts to medicare and solvency
none
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RETIRESAFE via RETIRESAFE
Source: Senate LDA
Worked within the Protect Medicare Part D working group to protect and improve Medicare Part D. Continued our support of 340B reform including our support of HR 4710, the Pause Act, which would improve oversight and increase program accountability. In January RetireSafe commented on the Proposed Rule on Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses released in the Federal Register on November 30, 2018. We proposed that the only meaningful change would be one that lowered the patients out-ot-pocket costs. Sent a letter to the Administration concerning some of the proposed changes to Medicare, especially Part D, that we felt threatened the access and safety of older Americans. talked about importance of vaccinations and accessibility. discussed our stance against drug importation.
Pharmaceutical Independence Long-Term Readiness Reform Act
Client: RETIRESAFE · Firm: RETIRESAFE
Worked within the Protect Medicare Part D working group to protect and improve Medicare Part D. Continued our support of 340B reform including our support of HR 4710, the Pause Act, which would improve oversight and increase program accountability. In January RetireSafe commented on the Proposed Rule on Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses released in the Federal Register on November 30, 2018. We proposed that the only meaningful change would be one that lowered the patients out-ot-pocket costs. Sent a letter to the Administration concerning some of the proposed changes to Medicare, especially Part D, that we felt threatened the access and safety of older Americans. talked about importance of vaccinations and accessibility. discussed our stance against drug importation.
Pharmaceutical Independence Long-Term Readiness Reform Act
Client: RETIRESAFE · Firm: RETIRESAFE
Worked within the Protect Medicare Part D working group to protect and improve Medicare Part D. Continued our support of 340B reform including our support of HR 4710, the Pause Act, which would improve oversight and increase program accountability. In January RetireSafe commented on the Proposed Rule on Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses released in the Federal Register on November 30, 2018. We proposed that the only meaningful change would be one that lowered the patients out-ot-pocket costs. Sent a letter to the Administration concerning some of the proposed changes to Medicare, especially Part D, that we felt threatened the access and safety of older Americans. talked about importance of vaccinations and accessibility. discussed our stance against drug importation.
Pharmaceutical Independence Long-Term Readiness Reform Act
Client: RETIRESAFE · Firm: RETIRESAFE
Worked within the Protect Medicare Part D working group to protect and improve Medicare Part D. Continued our support of 340B reform including our support of HR 4710, the Pause Act, which would improve oversight and increase program accountability. In January RetireSafe commented on the Proposed Rule on Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses released in the Federal Register on November 30, 2018. We proposed that the only meaningful change would be one that lowered the patients out-ot-pocket costs. Sent a letter to the Administration concerning some of the proposed changes to Medicare, especially Part D, that we felt threatened the access and safety of older Americans. talked about importance of vaccinations and accessibility. discussed our stance against drug importation.
Pharmaceutical Independence Long-Term Readiness Reform Act
Client: RETIRESAFE · Firm: RETIRESAFE
Worked within the Protect Medicare Part D working group to protect and improve Medicare Part D. Continued our support of 340B reform including our support of HR 4710, the Pause Act, which would improve oversight and increase program accountability. In January RetireSafe commented on the Proposed Rule on Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses released in the Federal Register on November 30, 2018. We proposed that the only meaningful change would be one that lowered the patients out-ot-pocket costs. Sent a letter to the Administration concerning some of the proposed changes to Medicare, especially Part D, that we felt threatened the access and safety of older Americans. talked about importance of vaccinations and accessibility. discussed our stance against drug importation.
Pharmaceutical Independence Long-Term Readiness Reform Act
Client: RETIRESAFE · Firm: RETIRESAFE
Worked within the Protect Medicare Part D working group to protect and improve Medicare Part D. Continued our support of 340B reform including our support of HR 4710, the Pause Act, which would improve oversight and increase program accountability. In January RetireSafe commented on the Proposed Rule on Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses released in the Federal Register on November 30, 2018. We proposed that the only meaningful change would be one that lowered the patients out-ot-pocket costs. Sent a letter to the Administration concerning some of the proposed changes to Medicare, especially Part D, that we felt threatened the access and safety of older Americans. talked about importance of vaccinations and accessibility. discussed our stance against drug importation.
Pharmaceutical Independence Long-Term Readiness Reform Act
Client: RETIRESAFE · Firm: RETIRESAFE
Worked within the Protect Medicare Part D working group to protect and improve Medicare Part D. Continued our support of 340B reform including our support of HR 4710, the Pause Act, which would improve oversight and increase program accountability. In January RetireSafe commented on the Proposed Rule on Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses released in the Federal Register on November 30, 2018. We proposed that the only meaningful change would be one that lowered the patients out-ot-pocket costs. Sent a letter to the Administration concerning some of the proposed changes to Medicare, especially Part D, that we felt threatened the access and safety of older Americans. talked about importance of vaccinations and accessibility. discussed our stance against drug importation.
2024 · third_quarter · Q3
cuts to medicare and solvency
none
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RETIRESAFE via RETIRESAFE
2024 · second_quarter · 2A
cuts to medicare and solvency
none
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RETIRESAFE via RETIRESAFE
2024 · first_quarter · Q1
none
cuts to medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RETIRESAFE via RETIRESAFE
2023 · fourth_quarter · Q4
cuts to medicare
none
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RETIRESAFE via RETIRESAFE
2023 · third_quarter · Q3
cuts to medicare
none
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RETIRESAFE via RETIRESAFE
2023 · second_quarter · Q2
cuts to medicare
none
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RETIRESAFE via RETIRESAFE
2023 · first_quarter · Q1
none
cuts to medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RETIRESAFE via RETIRESAFE
2022 · fourth_quarter · Q4
Medicare Part B
Part B
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RETIRESAFE via RETIRESAFE
2022 · third_quarter · Q3
Part B
Medicare Part B
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RETIRESAFE via RETIRESAFE
2022 · second_quarter · Q2
Part B
Medicare Part B
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RETIRESAFE via RETIRESAFE
2022 · first_quarter · Q1
Medicare Part B
Part B
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RETIRESAFE via RETIRESAFE
2021 · fourth_quarter · Q4
Medicare Part B
Part B
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RETIRESAFE via RETIRESAFE
2021 · third_quarter · Q3
Part B
Medicare Part B
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RETIRESAFE via RETIRESAFE
2021 · second_quarter · Q2
Medicare Part B
Part B
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RETIRESAFE via RETIRESAFE
2021 · first_quarter · Q1
Medicare Part B
Part B
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RETIRESAFE via RETIRESAFE
2020 · fourth_quarter · Q4
Worked within the Protect Medicare Part D working group to protect and improve Medicare Part D. Continued our support of 340B reform including our support of HR 4710, the Pause Act, which would improve oversight and increase program accountability. In January RetireSafe commented on the Proposed Rule on Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses released in the Federal Register on November 30, 2018. We proposed that the only meaningful change would be one that lowered the patients out-ot-pocket costs. Sent a letter to the Administration concerning some of the proposed changes to Medicare, especially Part D, that we felt threatened the access and safety of older Americans. talked about importance of vaccinations and accessibility. discussed our stance against drug importation.
discussed issues concerning overall healthcare related areas such as Medicare Part B and D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RETIRESAFE via RETIRESAFE
2020 · third_quarter · Q3
discussed issues concerning overall healthcare related areas such as Medicare Part B and D
Worked within the Protect Medicare Part D working group to protect and improve Medicare Part D. Continued our support of 340B reform including our support of HR 4710, the Pause Act, which would improve oversight and increase program accountability. In January RetireSafe commented on the Proposed Rule on Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses released in the Federal Register on November 30, 2018. We proposed that the only meaningful change would be one that lowered the patients out-ot-pocket costs. Sent a letter to the Administration concerning some of the proposed changes to Medicare, especially Part D, that we felt threatened the access and safety of older Americans. talked about importance of vaccinations and accessibility. discussed our stance against drug importation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RETIRESAFE via RETIRESAFE
2020 · second_quarter · Q2
Worked within the Protect Medicare Part D working group to protect and improve Medicare Part D. Continued our support of 340B reform including our support of HR 4710, the Pause Act, which would improve oversight and increase program accountability. In January RetireSafe commented on the Proposed Rule on Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses released in the Federal Register on November 30, 2018. We proposed that the only meaningful change would be one that lowered the patients out-ot-pocket costs. Sent a letter to the Administration concerning some of the proposed changes to Medicare, especially Part D, that we felt threatened the access and safety of older Americans. talked about importance of vaccinations and accessibility. discussed our stance against drug importation.
discussed issues concerning overall healthcare related areas such as Medicare Part B and D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RETIRESAFE via RETIRESAFE
2020 · first_quarter · Q1
Worked within the Protect Medicare Part D working group to protect and improve Medicare Part D. Continued our support of 340B reform including our support of HR 4710, the Pause Act, which would improve oversight and increase program accountability. In January RetireSafe commented on the Proposed Rule on Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses released in the Federal Register on November 30, 2018. We proposed that the only meaningful change would be one that lowered the patients out-ot-pocket costs. Sent a letter to the Administration concerning some of the proposed changes to Medicare, especially Part D, that we felt threatened the access and safety of older Americans. talked about importance of vaccinations and accessibility. discussed our stance against drug importation.
discussed issues concerning overall healthcare related areas such as Medicare Part B and D
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RETIRESAFE via RETIRESAFE
2019 · fourth_quarter · Q4
discussed issues concerning overall healthcare related areas such as Medicare Part B and D
Worked within the Protect Medicare Part D working group to protect and improve Medicare Part D. Continued our support of 340B reform including our support of HR 4710, the Pause Act, which would improve oversight and increase program accountability. In January RetireSafe commented on the Proposed Rule on Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses released in the Federal Register on November 30, 2018. We proposed that the only meaningful change would be one that lowered the patients out-ot-pocket costs. Sent a letter to the Administration concerning some of the proposed changes to Medicare, especially Part D, that we felt threatened the access and safety of older Americans. talked about importance of vaccinations and accessibility. discussed our stance against drug importation.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RETIRESAFE via RETIRESAFE
2019 · third_quarter · Q3
discussed issues concerning overall healthcare related areas such as Medicare Part B and D
Worked within the Protect Medicare Part D working group to protect and improve Medicare Part D. Continued our support of 340B reform including our support of HR 4710, the Pause Act, which would improve oversight and increase program accountability. In January RetireSafe commented on the Proposed Rule on Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses released in the Federal Register on November 30, 2018. We proposed that the only meaningful change would be one that lowered the patients out-ot-pocket costs. Sent a letter to the Administration concerning some of the proposed changes to Medicare, especially Part D, that we felt threatened the access and safety of older Americans. talked about importance of vaccinations and accessibility. discussed our stance against drug importation.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RETIRESAFE via RETIRESAFE
2019 · second_quarter · Q2
Lobbied the House and Senate to encourage a change in the bundled surgical payments to allow non-opioid pain solutions to be included.
discussed issues concerning overall healthcare related areas such as Medicare Part B and D
Worked within the Protect Medicare Part D working group to protect and improve Medicare Part D. Continued our support of 340B reform including our support of HR 4710, the Pause Act, which would improve oversight and increase program accountability. In January RetireSafe commented on the Proposed Rule on Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses released in the Federal Register on November 30, 2018. We proposed that the only meaningful change would be one that lowered the patients out-ot-pocket costs. Sent a letter to the Administration concerning some of the proposed changes to Medicare, especially Part D, that we felt threatened the access and safety of older Americans. talked about importance of vaccinations and accessibility. discussed our stance against drug importation.
RETIRESAFE via RETIRESAFE
2019 · first_quarter · Q1
Worked within the Protect Medicare Part D working group to protect and improve Medicare Part D. Continued our support of 340B reform including our support of HR 4710, the Pause Act, which would improve oversight and increase program accountability. In January RetireSafe commented on the Proposed Rule on Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses released in the Federal Register on November 30, 2018. We proposed that the only meaningful change would be one that lowered the patients out-ot-pocket costs. Sent a letter to the Administration concerning some of the proposed changes to Medicare, especially Part D, that we felt threatened the access and safety of older Americans. talked about importance of vaccinations and accessibility. discussed our stance against drug importation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE